No results for ‘’
Centenial Surgical Suture Ltd
₹97.05
(0%)
Wed, 16 Sept 2026, 11:40 pm
Health Technology
Medical Specialties
24.5KCentenial Surgical Suture Ratios
| Particulars | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0.43 | 0.36 | 1.91 | 4.64 | 9.60 | 9.90 | 15.84 | 15.65 | 19.40 | 8.94 | 9.80 | 16.22 | 35.34 | 25.40 | 29.38 | 0 |
| Price to book ratio | 0.05 | 0.05 | 0.18 | 0.42 | 0.89 | 0.89 | 1.09 | 1.10 | 1.15 | 0.64 | 0.44 | 0.53 | 0.73 | 0.72 | 1.03 | 1.30 |
| Price to sales ratio | 0.01 | 0.02 | 0.06 | 0.14 | 0.34 | 0.37 | 0.48 | 0.51 | 0.57 | 0.32 | 0.23 | 0.42 | 0.50 | 0.43 | 0.65 | 0.75 |
| Price to cash flow ratio | 0.27 | 0.41 | 0 | 11.54 | 0 | 91.21 | 0 | 0 | 16.36 | 11.95 | 6.93 | 0 | 7.78 | 17.57 | 8.90 | 3.01 |
| Enterprise value | 11.79Cr | 11.6Cr | 12.49Cr | 16.81Cr | 27.37Cr | 29.3Cr | 36.76Cr | 41.3Cr | 43.21Cr | 30.79Cr | 31.89Cr | 34.76Cr | 36.88Cr | 37.15Cr | 60.25Cr | 73.42Cr |
| Enterprise value to EBITDA ratio | 2.64 | 2.29 | 2.72 | 3.74 | 5.97 | 5.89 | 7.63 | 8.61 | 9.69 | 5.81 | 5.32 | 6.81 | 8.23 | 8.44 | 11.70 | 11.44 |
| Debt to equity ratio | 0.95 | 0.78 | 0.66 | 0.72 | 0.59 | 0.58 | 0.58 | 0.62 | 0.55 | 0.47 | 0.70 | 0.67 | 0.50 | 0.48 | 0.86 | 1.09 |
| Return on equity % | 0 | 15.57 | 9.97 | 9.43 | 9.75 | 9.46 | 7.09 | 7.27 | 6.10 | 7.45 | 4.57 | 3.31 | 2.10 | 2.89 | 3.58 | -4.65 |
Centenial Surgical Suture Ltd Ratios
The Centenial Surgical Suture Ltd Ratios page provides a complete fundamental analysis of Centenial Surgical Suture Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Centenial Surgical Suture Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.
Centenial Surgical Suture Ltd (NSE: , BSE: 531380) is currently trading at ₹97.05, with a market capitalization of ₹35.41Cr. As a major player in the Health technology sector and Medical specialties industry, Centenial Surgical Suture Ltd remains a key stock for fundamental analysis using Centenial Surgical Suture Ltd Ratios.
Centenial Surgical Suture Ltd Ratios: Valuation Overview
Price to Earnings Ratio (P/E)
The Centenial Surgical Suture Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Centenial Surgical Suture Ltd Ratios.
Historically, the Centenial Surgical Suture Ltd P/E ratio has shown strong fluctuations:
- 2024: 0
- 2023: 29.38
- 2022: 25.40
- 2021: 35.34
- 2020: 16.22
The decline in Centenial Surgical Suture Ltd P/E ratio suggests improving earnings relative to stock price.
Price to Book Ratio (P/B)
The Centenial Surgical Suture Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 1.30.
Historical P/B trend:
- 2024: 1.30
- 2023: 1.03
- 2022: 0.72
- 2021: 0.73
Centenial Surgical Suture Ltd shows reasonable valuation compared to its asset base.
Price to Sales Ratio (P/S)
The Centenial Surgical Suture Ltd P/S ratio currently stands at 0.75, an important part of Centenial Surgical Suture Ltd Ratios for revenue valuation.
Historical P/S ratio:
- 2024: 0.75
- 2023: 0.65
- 2022: 0.43
- 2021: 0.50
The rising Centenial Surgical Suture Ltd P/S ratio indicates improved revenue valuation by investors.
Centenial Surgical Suture Ltd Price to Cash Flow Ratio (P/CF)
The Centenial Surgical Suture Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 3.01.
Historical Centenial Surgical Suture Ltd Price to Cash Flow Ratio:
- 2024: 3.01
- 2023: 8.90
- 2022: 17.57
- 2021: 7.78
- 2020: 0
The declining Centenial Surgical Suture Ltd Price to Cash Flow Ratio suggests improving cash flow strength.
Centenial Surgical Suture Ltd Enterprise Value Ratios
Enterprise Value (EV)
The Centenial Surgical Suture Ltd EV currently stands at ₹73.42Cr, representing the total company valuation including debt.
Historical EV trend:
- 2024: 73.42Cr
- 2023: 60.25Cr
- 2022: 37.15Cr
- 2021: 36.88Cr
Centenial Surgical Suture Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.
EV/EBITDA Ratio
The Centenial Surgical Suture Ltd EV/EBITDA ratio is currently 11.44, a key metric in Centenial Surgical Suture Ltd Ratios to assess valuation relative to earnings.
Historical EV/EBITDA:
- 2024: 11.44
- 2023: 11.70
- 2022: 8.44
- 2021: 8.23
Stable Centenial Surgical Suture Ltd EV/EBITDA indicates balanced valuation.
Centenial Surgical Suture Ltd Financial Strength Ratios
Debt to Equity Ratio (D/E)
The Centenial Surgical Suture Ltd D/E ratio is currently 1.09, reflecting leverage and financial stability.
Historical D/E:
- 2024: 1.09
- 2023: 0.86
- 2022: 0.48
- 2021: 0.50
Higher D/E ratio indicates rising financial risk.
Return on Equity (ROE %)
The Centenial Surgical Suture Ltd ROE currently stands at -4.65%, showing profitability and capital efficiency.
Historical ROE:
- 2024: -4.65
- 2023: 3.58
- 2022: 2.89
- 2021: 2.10
Declining ROE indicates pressure on profitability.
Centenial Surgical Suture Ltd Ratios Analysis Summary
The Centenial Surgical Suture Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Centenial Surgical Suture Ltd stock is undervalued, fairly valued, or overvalued.
Tracking Centenial Surgical Suture Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.